Ocular Therapeutix, Inc. (NASDAQ:OCUL) Investor Day Conference Call June 13, 2024 2:00 PM ET Company Participants Bill Slattery - Vice President, Investor Relations Pravin Dugel - Executive Chairman, President and CEO Jeff Heier - Chief Scientific Officer Peter Kaiser - Chief Development Officer Nadia Waheed - Chief Medical Officer Barry Kuppermann - Steinert Professor and Chair, Department, Ophthalmology and Director, Gavin Herbert Eye Institute, UC, Irvine Dilsher Dhoot - Retina Consultants of America Don ...